• Explore /
  • Poster
  • / A phase II trial of AZD1775 plus carboplatin-paclitaxel in squamous cell lung cancer (SqCLC).

A phase II trial of AZD1775 plus carboplatin-paclitaxel in squamous cell lung cancer (SqCLC).

Abstract Poster

Authors

Bruna Pellini

Bruna Pellini

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Bruna Pellini , Jiannong Li , Michael J Schell , Michael Melendez , Tawee Tanvetyanon , Ben C. Creelan , Alberto Chiappori , Andreas Nicholas Saltos , Eric B. Haura , Michael Rahman Shafique , Trevor Rose , Farah Khalil , Stephanee Smikker , Sam Vafadar , Ashley Sansil , Jessica Wermuth , Milijana Ugrenovic-Petrovic , Alvaro N.A. Monteiro , Uwe Rix , Jhanelle E. Gray

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02513563

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 8545)

DOI

10.1200/JCO.2024.42.16_suppl.8545

Abstract #

8545

Poster Bd #

409

Abstract Disclosures

Similar Posters

First Author: Manish R. Patel

First Author: Irene Brana

First Author: Jianqing Zhu

First Author: Ana Oaknin